OnePlus has announced that its latest flagship handset – OnePlus 3 – is now available for purchase. The cost of the handset -- which went on sale via the OnePlus website at 12PM PT (3PM ET) on Tuesday -- begins at $399 (£309).
The new OnePlus 3 handset features 5.5inch 1080p AMOLED display, and is powered by Snapdragon 820 processor. It ships with a whopping 6GB of RAM and 64GB of non-expandable storage capacity.
Equipped with a massive 3,000mAh battery, the new OnePlus 3 handset features a 16-megapixel rear camera with optical image stabilization, and an 8-megapixel front-facing camera.
In addition, the OnePlus 3 handset has a fingerprint reader at the bottom; and comes with NFC capability, a USB Type-C port, an Alert Slider and OnePlus’ proprietary ‘Dash Charge’ fast-charging feature. Dash Charge can charge 60 percent of the handset’s battery in barely 30 minutes of charging.
The OnePlus 3 handset -- which can now be purchased by potential customers without the invite system -- has an attractive minimal, aluminium design; and is available in two options: ‘Graphite’ and ‘Soft Gold.’
The Verge has revealed in a Wednesday report, citing a statement released by Lexus, that the working of the head units of a number of vehicles has been affected because of an over-the-air (OTA) update recently rolled out by the company.
...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
In an announcement made at the I/O developer conference on Friday, tech biggie Google Advanced...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
In a recently-issued warning to civilian aviators, the...
In the last one week or so, a number of high-profile...
According to a TechCrunch report, social network...
Tech giant Google posted a video of a developer...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).
